Indocyanine green for parathyroid gland protection in complete endoscopic surgery for thyroid carcinoma through non-inflatable axillary approach

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100049512

Enrollment

Unknown

Registered

2021-08-02

Start date

2021-08-03

Completion date

Unknown

Last updated

2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid cancer

Interventions

Nano carbon group:Nano carbon

ICG group:indocyanine green

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Preoperative thyroid fine-needle aspiration to identify one side of papillary thyroid microcarcinoma, tumor diameter <= 1.0cm; 2. No history of thyroid surgery, no history of neck surgery, no history of ipsilateral chest and axillary surgery; 3. The patient has no cardiac and pulmonary insufficiency, abnormal coagulation function and other surgical contraindications. 4. Preoperative color Doppler ultrasound and CT showed no lymph node enlargement or suspicious metastatic nodules on the affected side, and no extraneous invasion was found. 5. The preoperative serum calcium and parathyroid hormone were within the normal range.

Exclusion criteria

Exclusion criteria: No.

Design outcomes

Primary

Measure	Time frame
Parathyroid Hormone;	—

Countries

China

Contacts

Public ContactYe Zhipeng

The First Affiliated Hospital of Zhejiang Chinese Medicine University

yezhipeng666@126.com+86 15968835273

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026